Workflow
Kala Pharmaceuticals (KALA) Investor Presentation - Slideshow

Innovation in Ophthalmology KPI – 012 Overview November 15, 2021 Safe Harbor and Disclaimer 2 This presentation contains forward-looking statements that involve substantial risks and uncertainties. Any statements in this presentation about our future expectations, plans and prospects, including but not limited to statements about our acquisition of Combangio, Inc. (the "Acquisition") and the other transactions contemplated by the Acquisition, and any other statements about future expectations, prospects, es ...